JPRN-UMIN000029085招募中未知
Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndrome - Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndrome
Gunma university graduate school of medicine0 个研究点目标入组 1 人开始时间: 2017年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1
研究概览
简要总结
The study was terminated because the target number of participants was not reached and the study was not evaluable.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. serum anti-acetylcholie receptor antibody positive 2. serum anti-MuSK antibody positive 3. pregnancy 4. epilepsy 5. iver dysfunction 6. renal dysfunction 7. abnormal ECG findings 8. the patient who judged inappropriate from the doctor
研究者
相似试验
已完成
不适用
DOMINIC - Non-interventional Study about Dose modifications of Docetaxel in the therapy of metastatic castration resistant Prostate CancerC61Malignant neoplasm of prostateDRKS00007955AxioNovo Gmbh168
已完成
4 期
Efficacy of coronary artery calcification on DenosumabPatients with osteoporosis with coronary artery calcificationosteoporosis, coronary artery calcificationJPRN-jRCT1031190025Kubota Naoki1
已完成
不适用
Study for necessity of insulin treatment in two enteral feeding formulas which are different in carbohydrates and fatty acids concentrations in tube-fed subjects with type 2 diabetes mellitustype 2 diabetes mellitus, Cerebral vascular diseaseJPRN-UMIN000001784Saiseikai Central Hospital40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40